Gerry Muhle with Carolyn Cameron, from Allergan
Allergan has celebrated fifty years of operation in Australia and New Zealand with a bold pop up exhibition featuring emerging Australian artists Claire Foxton, Elliot Routledge, George Rose, Joel Birch, Ling, Maid, and Scott Marsh.
Innovation & Impact – The Allergan Exhibition 2018, ran for just one night in late September in Sydney. It presented a collection of works that merged the worlds of science and art, highlighting the impact that Allergan and its products have had on the community. Each of the invited artists was briefed on an Allergan product and given the opportunity to engage with personal stories from within the patient community. They were given artistic freedom to interpret both the product and the patients’ experiences. The resulting diverse interpretive pieces ranged from wooden and neon sculptures to acrylic on canvas.
At the event, Gerry Muhle, Vice President and Managing Director of Allergan in Australia and New Zealand, thanked guests for their continued partnership with Allergan and spoke of the rationale behind the pop up exhibition. “Our culture is all about being bold and so… (to celebrate 50 years) we partnered and engaged with some of the most dynamic, leading urban artists in Australia today… and they interpreted some of our brands, and also interpreted how those iconic brands have impacted patients’ lives as well,” he said.
Of his response to the Xen implant, an acrylic on hand carved wood sculpture titled Instrument for Sight, (pictured), artist Elliot Routledge said, “This sculpture represents the implant itself. A long thin shape, which starts from the bottom with a blurry gradient and at the top becomes crisp and sharp”.